Literature DB >> 9101435

Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation.

L Chen1, B Liang, D E Froese, S Liu, J T Wong, K Tran, G M Hatch, D Mymin, E A Kroeger, R Y Man, P C Choy.   

Abstract

The elevated level of plasma low density lipoprotein (LDL) in hyperlipidemic patients is an important risk factor for the production of atherosclerosis. Plasma LDL must be modified before it can produce an impairment of endothelium-dependent relaxation in aortic rings or enhancement of uptake by macrophages. The dramatic increase in lysophosphatidylcholine (lysoPC) content in oxidatively modified LDL has been touted as an important biochemical factor for the impairment of endothelium-dependent relaxation. The present study was designed to examine the lysoPC composition of oxidized LDL samples from normal and hyperlipidemic subjects, and their effects on the impairment of endothelium-dependent relaxation. Oxidatively modified LDL from hyperlipidemic patients contained a slightly higher level (17%) of lysoPC, but produced a disproportionately greater impairment of endothelium-dependent relaxation than that from normal subjects. As lysoPC is composed of many molecular species, its composition in oxidized LDL samples was analyzed. In hyperlipidemic patients, lysoPC samples were found to contain a higher proportion of long-chain acyl groups. Subsequent studies revealed that only long-chain lysoPC (C > 16:0) were effective in impairing endothelium-dependent relaxation. Experimental loading of oxidized LDL from normal subjects with long chain lysoPC to mimic levels observed in oxidized LDL from hyperlipidemic patients resulted in further impairment of endothelium-dependent relaxation. We conclude that the greater proportion of long-chain lysoPC found in the oxidized LDL of hyperlipidemic subjects is responsible for the increased impairment of endothelium-dependent vascular relaxation. We propose that the high level of LDL found in the plasma of hyperlipidemic patients, coupled with its enhanced ability to generate long chain species of lysoPC during oxidative modification, are important factors for the development of atherosclerosis in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101435

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

Review 1.  To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.

Authors:  Gopal Kedihitlu Marathe; Chaitanya Pandit; Chikkamenahalli Lakshminarayana Lakshmikanth; Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Cletus Joseph Michael D'Souza
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

2.  Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.

Authors:  Maria P Kraemer; Guogen Mao; Courtney Hammill; Baoxiang Yan; Yu Li; Fredrick Onono; Susan S Smyth; Andrew J Morris
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

3.  Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.

Authors:  Jacinto López-Sagaseta; Leah V Sibener; Jennifer E Kung; Jenny Gumperz; Erin J Adams
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

4.  Integration of TRPC6 and NADPH oxidase activation in lysophosphatidylcholine-induced TRPC5 externalization.

Authors:  Pinaki Chaudhuri; Michael A Rosenbaum; Lutz Birnbaumer; Linda M Graham
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-23       Impact factor: 4.249

5.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.

Authors:  Monika Riederer; Pauli J Ojala; Andelko Hrzenjak; Wolfgang F Graier; Roland Malli; Michaela Tritscher; Martin Hermansson; Bernhard Watzer; Horst Schweer; Gernot Desoye; Akos Heinemann; Sasa Frank
Journal:  J Lipid Res       Date:  2010-07-07       Impact factor: 5.922

6.  The effect of fenofibrate treatment on endothelium-dependent relaxation induced by oxidative modified low density lipoprotein from hyperlipidemic patients.

Authors:  B Liang; J C McMaster; E A Kroeger; G M Hatch; D Mymin; T Dembinski; G Arthur; G Shen; R Y Man; P C Choy
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

7.  Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients.

Authors:  Q Zhu; J McMaster; D Mymin; T Dembinski; G Hatch; P C Choy; E A Kroeger
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

8.  Detrimental vascular effects of lysophosphatidylcholine is limited by other phospholipid components of low-density lipoprotein.

Authors:  Susan W S Leung; Min Huang; Ricky Y K Man
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

9.  Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease.

Authors:  Seong Hun Hong; Hyun Hee Jang; So Ra Lee; Kyung Hye Lee; Jong Shin Woo; Jin Bae Kim; Woo-Shik Kim; Byung Il Min; Ki Ho Cho; Kwon Sam Kim; Xianwu Cheng; Weon Kim
Journal:  Heart Vessels       Date:  2014-02-09       Impact factor: 2.037

10.  Hypercholesterolemia inhibits re-endothelialization of arterial injuries by TRPC channel activation.

Authors:  Michael A Rosenbaum; Pinaki Chaudhuri; Linda M Graham
Journal:  J Vasc Surg       Date:  2014-05-10       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.